DOPAMINE HYDROCHLORIDE — all Canadian products
8 DINs
3 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is DOPAMINE HYDROCHLORIDE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 00761850 | DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP | BAXTER CORPORATION | Solution | Intravenous | DOPAMINE HYDROCHLORIDE 0.8 MG; DEXTROSE 50 MG | Marketed | |
| 00761826 | DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP | BAXTER CORPORATION | Solution | Intravenous | DOPAMINE HYDROCHLORIDE 1.6 MG; DEXTROSE 50 MG | Marketed | |
| 00761834 | DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP | BAXTER CORPORATION | Solution | Intravenous | DOPAMINE HYDROCHLORIDE 3.2 MG; DEXTROSE 50 MG | Marketed | |
| 00423823 | DOPAMINE HCL INJ 4% | INTERNATIONAL MEDICATION SYSTEMS LTD. | Liquid | Intravenous | DOPAMINE HYDROCHLORIDE 40 MG | Cancelled Post Market | |
| 00619698 | DOPAMINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION USP | HOSPIRA HEALTHCARE ULC | Solution | Intravenous | DOPAMINE HYDROCHLORIDE 1.6 MG; DEXTROSE 50 MG | Cancelled Post Market | |
| 00782394 | DOPAMINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION USP | HOSPIRA HEALTHCARE ULC | Solution | Intravenous | DOPAMINE HYDROCHLORIDE 3.2 MG; DEXTROSE 50 MG | Cancelled Post Market | |
| 00619701 | DOPAMINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION USP | HOSPIRA HEALTHCARE ULC | Solution | Intravenous | DOPAMINE HYDROCHLORIDE 0.8 MG; DEXTROSE 50 MG | Cancelled Post Market | |
| 01914014 | INTROPIN INJECTION 40MG/ML | BRISTOL-MYERS SQUIBB CANADA | Solution | Intravenous | DOPAMINE HYDROCHLORIDE 40 MG | Cancelled Post Market |
Browse other molecules: